meshcan
5 minutes ago
Yeah, I think so. We know Vyvanse market size is $4.3B but with 10+ generic I've heard it might have been shrunk to $2.5B, so taking 10% of market share will be $250M. I believe someone here said we've gained 20% market share on Adderall. So, 10% of Vyvanse is conservative in my opinion.